Published in NMR Biomed on July 29, 2016
Temozolomide arrests glioma growth and normalizes intratumoral extracellular pH. Sci Rep (2017) 0.75
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Why do cancers have high aerobic glycolysis? Nat Rev Cancer (2004) 20.60
Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res (2009) 3.40
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012. Neuro Oncol (2015) 3.21
Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res (1996) 3.11
Dysregulated pH: a perfect storm for cancer progression. Nat Rev Cancer (2011) 3.10
Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res (2006) 3.10
pH imaging. A review of pH measurement methods and applications in cancers. IEEE Eng Med Biol Mag (2004) 2.68
Acidity generated by the tumor microenvironment drives local invasion. Cancer Res (2013) 2.63
Clinical pharmacokinetics of probenecid. Clin Pharmacokinet (1981) 2.44
Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas. J Neurooncol (2009) 2.33
The potential role of systemic buffers in reducing intratumoral extracellular pH and acid-mediated invasion. Cancer Res (2009) 1.92
Responsive MRI agents for sensing metabolism in vivo. Acc Chem Res (2009) 1.84
Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology. Biopharm Drug Dispos (2010) 1.74
Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases. Neurobiol Dis (2009) 1.70
Significance of nitroimidazole compounds and hypoxia-inducible factor-1 for imaging tumor hypoxia. Cancer Sci (2009) 1.51
Evaluations of extracellular pH within in vivo tumors using acidoCEST MRI. Magn Reson Med (2013) 1.48
Acid treatment of melanoma cells selects for invasive phenotypes. Clin Exp Metastasis (2008) 1.44
Combined vascular and extracellular pH imaging of solid tumors. NMR Biomed (2002) 1.44
Imaging the extracellular pH of tumors by MRI after injection of a single cocktail of T1 and T2 contrast agents. NMR Biomed (2011) 1.40
Mapping extracellular pH in rat brain gliomas in vivo by 1H magnetic resonance spectroscopic imaging: comparison with maps of metabolites. Cancer Res (2001) 1.34
Mrp1 multidrug resistance-associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells. J Neurochem (1998) 1.31
Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs. Annu Rev Pharmacol Toxicol (2005) 1.23
Quantitative tissue pH measurement during cerebral ischemia using amine and amide concentration-independent detection (AACID) with MRI. J Cereb Blood Flow Metab (2014) 1.15
In situ 3D magnetic resonance metabolic imaging of microwave-irradiated rodent brain: a new tool for metabolomics research. J Neurochem (2009) 1.13
Brain temperature and pH measured by (1)H chemical shift imaging of a thulium agent. NMR Biomed (2009) 1.04
Brain temperature by Biosensor Imaging of Redundant Deviation in Shifts (BIRDS): comparison between TmDOTP5- and TmDOTMA-. NMR Biomed (2010) 1.01
Ultrashort TE chemical shift imaging (UTE-CSI). Magn Reson Med (2005) 1.00
A lanthanide complex with dual biosensing properties: CEST (chemical exchange saturation transfer) and BIRDS (biosensor imaging of redundant deviation in shifts) with europium DOTA-tetraglycinate. NMR Biomed (2011) 0.97
Brain tumor perfusion: comparison of dynamic contrast enhanced magnetic resonance imaging using T1, T2, and T2* contrast, pulsed arterial spin labeling, and H2(15)O positron emission tomography. Eur J Radiol (2008) 0.97
In vivo three-dimensional molecular imaging with Biosensor Imaging of Redundant Deviation in Shifts (BIRDS) at high spatiotemporal resolution. NMR Biomed (2013) 0.96
The history and future of probenecid. Cardiovasc Toxicol (2012) 0.95
Neuro-oncology in 2015: Progress in glioma diagnosis, classification and treatment. Nat Rev Neurol (2016) 0.94
Effect of probenecid on fluorescein transport in the central nervous system using in vitro and in vivo models. Pharm Res (2001) 0.92
In vivo characterization of several rodent glioma models by 1H MRS. NMR Biomed (2011) 0.92
Choroid plexus controls brain availability of anti-HIV nucleoside analogs via pharmacologically inhibitable organic anion transporters. AIDS (2003) 0.90
Organic anion transporter 3 mediates the efflux transport of an amphipathic organic anion, dehydroepiandrosterone sulfate, across the blood-brain barrier in mice. Drug Metab Dispos (2011) 0.88
Diffusion tensor and perfusion imaging of brain tumors in high-field MR imaging. Neuroimaging Clin N Am (2012) 0.87
Lanthanide ion (III) complexes of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraaminophosphonate for dual biosensing of pH with chemical exchange saturation transfer (CEST) and biosensor imaging of redundant deviation in shifts (BIRDS). Contrast Media Mol Imaging (2014) 0.86
Imaging the microvessel caliber and density: Principles and applications of microvascular MRI. Magn Reson Med (2014) 0.84
Consequences of inhibition of bumetanide metabolism in rodents on brain penetration and effects of bumetanide in chronic models of epilepsy. Eur J Neurosci (2013) 0.83
Probenecid inhibits the metabolic and renal clearances of zidovudine (AZT) in human volunteers. Pharm Res (1990) 0.83
The effect of probenecid on the renal tubular excretion of benzylpenicillin. Br J Clin Pharmacol (1988) 0.82
GdDO3NI, a nitroimidazole-based T1 MRI contrast agent for imaging tumor hypoxia in vivo. J Biol Inorg Chem (2013) 0.81
Dendrimer-Based Responsive MRI Contrast Agents (G1-G4) for Biosensor Imaging of Redundant Deviation in Shifts (BIRDS). Bioconjug Chem (2015) 0.81
The effect of organic anion transporter 3 inhibitor probenecid on bumetanide levels in the brain: an integrated in vivo microdialysis study in the rat. J Pharm Pharmacol (2014) 0.81
Increased tumour extracellular pH induced by Bafilomycin A1 inhibits tumour growth and mitosis in vivo and alters 5-fluorouracil pharmacokinetics. Eur J Cancer (2003) 0.80
Characterization of a lanthanide complex encapsulated with MRI contrast agents into liposomes for biosensor imaging of redundant deviation in shifts (BIRDS). J Biol Inorg Chem (2014) 0.80
Imaging the intratumoral-peritumoral extracellular pH gradient of gliomas. NMR Biomed (2016) 0.79
MR - eyes for cancer: looking within an impenetrable disease. NMR Biomed (2013) 0.79
Effects of semistarvation on the distribution of erythrocytes and plasma in organs and tissues of the rat. J Nutr (1958) 0.78
Temozolomide arrests glioma growth and normalizes intratumoral extracellular pH. Sci Rep (2017) 0.75
Improved specific loss power on cancer cells by hyperthermia and MRI contrast of hydrophilic Fex Co1-x Fe2 O4 nanoensembles. Contrast Media Mol Imaging (2016) 0.75